The iconic rise of Viagra has consistently remained a symbol of pharmaceutical success, however its legacy within the broader industry now presents questions about potential gains. Alternative versions are undercutting market share, prompting concerns that betting on companies closely tied to Viagra's former position could be a speculative strategy